No Data
No Data
Fast running on the growth road and winning the adversity market with the “continuous highest profit forecast” stock for the current fiscal year ending 2 months! <Stock Search Top Feature>
From the latter half of this week, we will enter the main financial results announcement season for companies with financial results for the fiscal year ending March 31. According to the Tokyo Stock Exchange's tally (as of the 18th), starting with Nidec [Tokyo Stock Exchange P], which is scheduled to be announced on the 23rd, approximately 280 companies will refrain from making announcements by the end of April, and over 1800 companies after Golden Week. While semiconductor market conditions are expected to recover and high levels of capital investment needs continue for the fiscal year ending 25/3, there are many people who see a continued upward trend in profit. Expectations for good performance were also the driving force for the Nikkei Stock Average to hit an all-time high.
Front market [stocks that have moved, stocks that have been created]
*TERRASKY <3915> 1670 Ka - I like the forecast for a significant increase in profit and the NTT DATA capital alliance. *BayCurrent <6532> 3453 - In addition to dividend increases and share buybacks, medium-term sales growth targets were also evaluated. *IDOM <7599> 1383 +300 This fiscal year is expected to increase significantly more than market expectations. *Sales deficit was revised upward to a drastic reduction with GUNOSY <6047> 796 +100 Game Eight as the driving force. *vector <6058> 1305 +158 consecutive for this term
Is the downturn, weak US stocks, and the situation in the Middle East heavy, but is the lower price stiff
[Emerging Markets Individual Stock Strategy] Today's emerging markets are expected to develop softly. In the US stock market on the 12th of last weekend, the Dow average depreciated by 475.84 dollars (-1.24%) to 37,983.24 dollars and continued to drop drastically for 5 days. Dull bank accounts, a sense of caution against the tense situation in the Middle East, and declining expectations for interest rate cuts from the Federal Reserve (Fed) weighed on stock prices and remained soft throughout the day. The decline widened towards the end of the game. Today's emerging markets are likely to be dominated by sales. US stocks last weekend
Astellas Pharmaceuticals, 24/3 revised downward operating profit 13 billion yen ← 83 billion yen
Astellas Pharmaceuticals <4503> announced revisions to its earnings forecast for the fiscal year ending 2024/3. Operating profit was revised downward from 83 billion yen to 13 billion yen. As a result of reviewing the asset value of the gene therapy program AT808, which is undergoing research and development for Friedreich ataxia patients, impairment losses of approximately 40 billion yen of intangible assets related to AT808 will be recorded as other expenses. [Positive Evaluation] <8233>Takashimaya Full Year | <6432>Takeuchi Production
Bic Camera, Money Forward, Ryohin Keikaku, Takashimaya (12 days)
*The above calendar is just a schedule and is subject to change due to company circumstances. ---------------------------------------4/12 (Fri) <1401>mbs <1407>West HD<1418>Interlife <1434>JESCOHD<2153>Ejay HD <2168>Pasona G<2305>Studio Alice <2379>dip
Tama Home, Lawson, Hisamitsuyaku, Fast Lite (11 days)
*The above calendar is just a schedule and is subject to change due to company circumstances. ---------------------------------------4/11 (Thu) <137A>Cocolive <1419>Tama Home <2341>Part-time job in Thailand <2459>Aung <2651>Lawson <2742>Harrows<2791>Daikokuten <2882>Eat and
No Data